Page last updated: 2024-10-28

4-fluorohexahydrosiladifenidol and Colonic Neoplasms

4-fluorohexahydrosiladifenidol has been researched along with Colonic Neoplasms in 2 studies

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
"Most colon cancers overexpress M3 muscarinic receptors (M3R), and post-M3R signaling stimulates human colon cancer cell proliferation."1.35Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. ( Cheng, K; Davis, RJ; Drachenberg, C; Nomikos, G; Raufman, JP; Samimi, R; Shant, J; Wade, M; Xie, G, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, K1
Samimi, R1
Xie, G1
Shant, J1
Drachenberg, C1
Wade, M1
Davis, RJ1
Nomikos, G1
Raufman, JP1
Kerr, PM1
Hillier, K1
Wallis, RM1
Garland, CJ1

Other Studies

2 other studies available for 4-fluorohexahydrosiladifenidol and Colonic Neoplasms

ArticleYear
Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:3

    Topics: Acetylcholine; Acetylcholinesterase; Atropine; Autocrine Communication; Caco-2 Cells; Cell Prolifera

2008
Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.
    British journal of pharmacology, 1995, Volume: 115, Issue:8

    Topics: Alkaloids; Atropine; Carbachol; Carcinoma; Colon; Colonic Neoplasms; Dose-Response Relationship, Dru

1995